Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
Sutro Biopharma, Inc. (STRO) had Book Value Per Share of $-7.98 for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$9.10M |
|
$-31.49M |
|
-- |
|
$9.10M |
|
$31.05M |
|
$-21.96M |
|
$-9.53M |
|
$-31.49M |
|
$-31.49M |
|
$-31.49M |
|
$-31.49M |
|
$-31.49M |
|
$-31.49M |
|
$-21.96M |
|
$-21.01M |
|
16.58M |
|
16.58M |
|
$-1.90 |
|
$-1.90 |
|
| Balance Sheet Financials | |
$159.50M |
|
$7.13M |
|
$17.15M |
|
$176.65M |
|
$54.31M |
|
-- |
|
$254.87M |
|
$309.18M |
|
$-132.54M |
|
$-132.54M |
|
$-132.54M |
|
16.60M |
|
| Cash Flow Statement Financials | |
$-103.00M |
|
$-11.07M |
|
$102.79M |
|
$58.99M |
|
$47.71M |
|
$-11.28M |
|
$5.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-241.33% |
|
-241.33% |
|
-- |
|
-346.11% |
|
-346.11% |
|
$-103.14M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
0.71 |
|
126.77 |
|
23.76% |
|
23.76% |
|
-17.83% |
|
23.76% |
|
|
Book Value Per Share |
$-7.98 |
$-6.22 |
|
$-6.21 |
|